Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer
Open Access
- 1 January 2014
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 20 (31) , 10813-24
Abstract
Pancreatic cancer continues to be a leading cause of cancer-related death worldwide and there is an urgent need to develop novel diagnostic and therapeutic strategies to reduce the mortality of patients with this disease. In pancreatic cancer, some tight junction proteins, including claudins, are abnormally regulated and therefore are promising molecular targets for diagnosis, prognosis and therapy. Claudin-4 and -18 are overexpressed in human pancreatic cancer and its precursor lesions. Claudin-4 is a high affinity receptor of Clostridium perfringens enterotoxin (CPE). The cytotoxic effects of CPE and monoclonal antibodies against claudin-4 are useful as novel therapeutic tools for pancreatic cancer. Claudin-18 could be a putative marker and therapeutic target with prognostic implications for patients with pancreatic cancer. Claudin-1, -7, tricellulin and marvelD3 are involved in epithelial to mesenchymal transition (EMT) of pancreatic cancer cells and thus might be useful as biomarkers during disease. Protein kinase C is closely related to EMT of pancreatic cancer and regulates tight junctions of normal human pancreatic duct epithelial cells and the cancer cells. This review focuses on the regulation of tight junctions via protein kinase C during EMT in human pancreatic cancer for the purpose of developing new diagnostic and therapeutic modalities for pancreatic cancer.Keywords
This publication has 136 references indexed in Scilit:
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Predicted expansion of the claudin multigene familyFEBS Letters, 2011
- The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cellsThe EMBO Journal, 2011
- Phorbol ester phorbol‐12‐myristate‐13‐acetate induces epithelial to mesenchymal transition in human prostate cancer ARCaPE cellsThe Prostate, 2010
- Protein kinase Cα: disease regulator and therapeutic targetTrends in Pharmacological Sciences, 2010
- JNK signalling modulates intestinal homeostasis and tumourigenesis in miceThe EMBO Journal, 2009
- Oncogenic Function of ATDC in Pancreatic Cancer through Wnt Pathway Activation and β-Catenin StabilizationCancer Cell, 2009
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 2007
- Signalling to and from tight junctionsNature Reviews Molecular Cell Biology, 2003
- The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cellsNature Cell Biology, 2000